Drugs / VHH batch 203027
VHH batch 203027
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01259765 Comparator | Jan 2006 → Sep 2008 | infantile diarrhea | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VHH batch 203027 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01259765 ↗ |
| Known as | anti-rotavirus protein | “We assessed the efficacy of a llama-derived, heavy-chain antibody fragment called anti-rotavirus protein (ARP1), in modifying the severity and duration of diarrhea in male...” PMID 23831050 ↗ Jul 2013 |
| Known as | ARP1 | “We assessed the efficacy of a llama-derived, heavy-chain antibody fragment called anti-rotavirus protein (ARP1), in modifying the severity and duration of diarrhea in male...” PMID 23831050 ↗ Jul 2013 |
| Modality | Protein / enzyme biologic | “a llama-derived, heavy-chain antibody fragment” PMID 23831050 ↗ Jul 2013 |
| Route | Oral | “oral administration of VHH antibody fragment” NCT01259765 ↗ |